157 related articles for article (PubMed ID: 30350295)
1. Analysis of Drugs in Oral Fluid Using LC-MS/MS.
Coulter CA; Moore CM
Methods Mol Biol; 2019; 1872():237-259. PubMed ID: 30350295
[TBL] [Abstract][Full Text] [Related]
2. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.
Heltsley R; DePriest A; Black DL; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
J Anal Toxicol; 2011 Oct; 35(8):529-40. PubMed ID: 22004671
[TBL] [Abstract][Full Text] [Related]
3. Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Coulter C; Garnier M; Moore C
J Anal Toxicol; 2022 Oct; 46(8):899-904. PubMed ID: 35640884
[TBL] [Abstract][Full Text] [Related]
4. Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS.
West R; Mikel C; Hofilena D; Guevara M
Drug Alcohol Depend; 2018 Dec; 193():183-191. PubMed ID: 30391868
[TBL] [Abstract][Full Text] [Related]
5. Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine.
Vindenes V; Yttredal B; Oiestad EL; Waal H; Bernard JP; Mørland JG; Christophersen AS
J Anal Toxicol; 2011 Jan; 35(1):32-9. PubMed ID: 21219701
[TBL] [Abstract][Full Text] [Related]
6. Determination of 21 drugs in oral fluid using fully automated supported liquid extraction and UHPLC-MS/MS.
Valen A; Leere Øiestad ÅM; Strand DH; Skari R; Berg T
Drug Test Anal; 2017 May; 9(5):808-823. PubMed ID: 27464485
[TBL] [Abstract][Full Text] [Related]
7. Current technologies and considerations for drug bioanalysis in oral fluid.
Gallardo E; Barroso M; Queiroz JA
Bioanalysis; 2009 Jun; 1(3):637-67. PubMed ID: 21083159
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
Cone EJ; Clarke J; Tsanaclis L
J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455
[TBL] [Abstract][Full Text] [Related]
9. Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure.
Blandino V; Wetzel J; Kim J; Haxhi P; Curtis R; Concheiro M
Curr Pharm Biotechnol; 2017; 18(10):796-805. PubMed ID: 29173162
[TBL] [Abstract][Full Text] [Related]
10. QuEChERS sample preparation prior to LC-MS/MS determination of opiates, amphetamines, and cocaine metabolites in whole blood.
Dulaurent S; El Balkhi S; Poncelet L; Gaulier JM; Marquet P; Saint-Marcoux F
Anal Bioanal Chem; 2016 Feb; 408(5):1467-74. PubMed ID: 26753977
[TBL] [Abstract][Full Text] [Related]
11. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.
Wille SM; Raes E; Lillsunde P; Gunnar T; Laloup M; Samyn N; Christophersen AS; Moeller MR; Hammer KP; Verstraete AG
Ther Drug Monit; 2009 Aug; 31(4):511-9. PubMed ID: 19571773
[TBL] [Abstract][Full Text] [Related]
12. Drugs of abuse in oral fluid collected by two different sample kits--stability testing and validation using ultra performance tandem mass spectrometry analysis.
Lund HM; Øiestad EL; Gjerde H; Christophersen AS
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3367-77. PubMed ID: 21962269
[TBL] [Abstract][Full Text] [Related]
13. Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry.
Fritch D; Blum K; Nonnemacher S; Haggerty BJ; Sullivan MP; Cone EJ
J Anal Toxicol; 2009; 33(9):569-77. PubMed ID: 20040131
[TBL] [Abstract][Full Text] [Related]
14. A validated workflow for drug detection in oral fluid by non-targeted liquid chromatography-tandem mass spectrometry.
Reinstadler V; Lierheimer S; Boettcher M; Oberacher H
Anal Bioanal Chem; 2019 Feb; 411(4):867-876. PubMed ID: 30519959
[TBL] [Abstract][Full Text] [Related]
15. Comparing presumptive with direct-to-definitive drug testing in oral fluid vs. urine for a U.S. national sample of individuals misusing drugs.
Magura S; Lee-Easton MJ; Abu-Obaid R; Reed P; Allgaier B; Amaratunga P; Lorenz-Lemberg B; Levitas M; Achtyes ED
Drug Alcohol Depend; 2023 Sep; 250():110894. PubMed ID: 37481872
[TBL] [Abstract][Full Text] [Related]
16. A new ultraperformance-tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications.
Huestis MA
Clin Chem; 2009 Dec; 55(12):2079-81. PubMed ID: 19833833
[No Abstract] [Full Text] [Related]
17. Ultra-rapid targeted analysis of 40 drugs of abuse in oral fluid by LC-MS/MS using carbon-13 isotopes of methamphetamine and MDMA to reduce detector saturation.
Di Rago M; Chu M; Rodda LN; Jenkins E; Kotsos A; Gerostamoulos D
Anal Bioanal Chem; 2016 May; 408(14):3737-49. PubMed ID: 26993306
[TBL] [Abstract][Full Text] [Related]
18. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
[TBL] [Abstract][Full Text] [Related]
19. Roche DAT immunoassay: sensitivity and specificity testing for amphetamines, cocaine, and opiates in oral fluid.
Crooks CR; Brown S
J Anal Toxicol; 2010 Mar; 34(2):103-9. PubMed ID: 20223103
[TBL] [Abstract][Full Text] [Related]
20. Oral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations.
Truver MT; Palmquist KB; Swortwood MJ
J Anal Toxicol; 2019 Sep; 43(8):637-643. PubMed ID: 31504595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
